Targeting membrane androgen receptors in tumors

@article{Lang2013TargetingMA,
  title={Targeting membrane androgen receptors in tumors},
  author={Florian Lang and Konstantinos Alevizopoulos and Christos Stournaras},
  journal={Expert Opinion on Therapeutic Targets},
  year={2013},
  volume={17},
  pages={951 - 963}
}
Introduction: In the last decade androgen actions that are originated from non-genomic, rapid signaling have been described in a large number of cell models and tissues. These effects are initiated through the stimulation of membrane androgen-binding sites or receptors (mAR). Although the molecular identity of mARs remains elusive, their activation is known to trigger multiple non-genomic signaling cascades and to regulate numerous cell responses. In recent years specific interest is being paid… Expand
Membrane Androgen Receptors Unrelated to Nuclear Steroid Receptors.
  • P. Thomas
  • Medicine, Chemistry
  • Endocrinology
  • 2019
TLDR
The current status of these four proteins as membrane androgen receptors (mARs or sensors) or sensors is critically reviewed. Expand
ICRAC controls the rapid androgen response in human primary prostate epithelial cells and is altered in prostate cancer
TLDR
It is demonstrated that this DHT induced Ca2+ influx via Orai1 is important for rapid androgen triggered prostate specific antigen (PSA) release and alterations of the molecular components of CRAC channels in prostate cancer are identified. Expand
Non-nuclear AR Signaling in Prostate Cancer
TLDR
An exhaustive state-of-the-art overview of the non-genomic role of AR in PCa, with particular emphasis on its involvement in TME biology is furnishing an in-depth look at current literature. Expand
Membrane Androgen Receptor Down-Regulates c-Src-Activity and Beta-Catenin Transcription and Triggers GSK-3beta-Phosphorylation in Colon Tumor Cells
TLDR
There is strong evidence that mAR activation regulates late expression and/or activity of the tumorigenic gene products c-Src, GSK-3beta, and beta-catenin thus facilitating the pro-apoptotic response in colon tumor cells. Expand
Inhibition of SGK1 enhances mAR-induced apoptosis in MCF-7 breast cancer cells
TLDR
The results demonstrate that mAR activation triggers pro-apoptotic responses in breast tumor cells, an effect significantly enhanced by SGK1 inhibition, involving actin reorganization and paralleled by down-regulation of FAK/Akt signaling. Expand
Membrane androgen receptor characteristics of human ZIP9 (SLC39A) zinc transporter in prostate cancer cells: Androgen-specific activation and involvement of an inhibitory G protein in zinc and MAP kinase signaling
TLDR
Results show ZIP9 is a specific Gi coupled-mAR mediating testosterone-induced MAP kinase and zinc signaling in PC3-ZIP9 cells, suggesting ZIP9 also regulates free zinc through releasing it from these intracellular organelles. Expand
Recent Advances in Drug Design and Drug Discovery for Androgen-Dependent Diseases
TLDR
The importance of different targets such as 5α-reductase, 17β-HSD, CYP17A, androgen receptor and protein kinase A for the treatment of prostate cancer and benign prostatic hyperplasia is summarized. Expand
Up-regulation of Orai1 expression and store operated Ca2+ entry following activation of membrane androgen receptors in MCF-7 breast tumor cells
TLDR
mAR sensitive Rac1 activation and actin reorganization contribute to the regulation of Orai1 protein abundance and SOCE by mAR. Expand
Membrane androgen receptor sensitive Na+/H+ exchanger activity in prostate cancer cells
Membrane androgen receptors (mAR) are expressed in several tumors. mAR activation by testosterone albumin conjugates (TAC) suppresses tumor growth and migration. mAR signaling involvesExpand
Functional characterization and anti-cancer action of the clinical phase II cardiac Na+/K+ ATPase inhibitor istaroxime: in vitro and in vivo properties and cross talk with the membrane androgen receptor
TLDR
Results support a multi-level action of Na+/K+ ATPase inhibitors in cancer cells and collectively validate istaroxime as a strong re-purposing candidate for further cancer drug development. Expand
...
1
2
3
...

References

SHOWING 1-10 OF 115 REFERENCES
Membrane androgen receptor activation in prostate and breast tumor cells: Molecular signaling and clinical impact
TLDR
This review summarizes the specific cellular events attributed to mAR activation and the experimental results on distinct non‐genomic signaling cascades operating in various tumor cells independently of the iAR and discusses the crucial role of actin cytoskeleton organization and signaling in mediating mAR responses. Expand
Activation of membrane androgen receptors potentiates the antiproliferative effects of paclitaxel on human prostate cancer cells
TLDR
It is suggested that chronic activation of membrane androgen receptors in vitro and in vivo facilitates and sustains for a longer time the antitumoral action of cytoskeletal acting agents. Expand
Membrane-initiated steroid action in breast and prostate cancer
TLDR
The identification and signaling events of membrane-initiated steroid (androgen and estrogen) action in breast and prostate cancer cell lines and clinical specimens are reviewed and the interaction of cytokine/growth factor receptors with membrane-acting steroids and their potential clinical implications are discussed. Expand
Abstract 1728: Membrane androgen receptor ligands: a novel therapeutic approach for the treatment of cancer
TLDR
Novel small molecule steroidal mAR ligands that exhibit in vitro anti-cancer activity in the nanomolar range in prostate cancer cell lines are described and it is shown that selective novel m AR ligands exert broad anti- cancer action in additional cell line panels including colon, non-small cell lung cancer, central nervous system, breast or multi drug resistant cells. Expand
Membrane testosterone binding sites in prostate carcinoma as a potential new marker and therapeutic target: Study in paraffin tissue sections
TLDR
It is concluded that membrane androgen receptors may represent an index of tumor aggressiveness and possibly specific targets for new therapeutic regimens. Expand
Membrane androgen receptor activation induces apoptotic regression of human prostate cancer cells in vitro and in vivo.
TLDR
Evidence is provided that activation of mAR by nonpermeable, BSA-coupled testosterone results in inhibition of L NCaP cell growth and induction in LNCaP cells of both apoptosis and the proapoptotic Fas protein, suggesting that activators of m AR may represent a new class of antitumoral agents of prostate cancer. Expand
Rapid actions of androgens
TLDR
This review will focus on the rapid effects of androgen on cell surface and cytoplasmic level, which suggests a cross-talk between the fast non-genomic and the slow genomic pathway of androgens. Expand
The prostate plasma membrane as an androgen receptor.
TLDR
It is discovered that the sodium-potassium-dependent ATPase of the prostate plasma membrane binds androgen, and is activated by the hormone's presence to serve as a metabolic pacemaker. Expand
Opposing effects of estradiol- and testosterone-membrane binding sites on T47D breast cancer cell apoptosis.
TLDR
The findings suggest that aromatase inhibitors may exert their beneficial effects on breast cancer by also propagating the metabolism of local steroids towards androgen, inducing thus cell apoptosis through membrane androgen receptor activation. Expand
Functional membrane androgen receptors in colon tumors trigger pro-apoptotic responses in vitro and reduce drastically tumor incidence in vivo
TLDR
It is demonstrated for the first time that functional mARs are predominantly expressed in colon tumors and that their activation results in induction of anti-tumor responses in vitro and extensive reduction of tumor incidence in vivo. Expand
...
1
2
3
4
5
...